Indegene Ltd

Indegene Ltd, a healthcare services company, recorded a new 52-week low of Rs.424.25 today, marking a significant milestone in its recent price trajectory. This decline comes after a sustained period of downward movement, reflecting a combination of market pressures and company-specific performance factors.

Indegene Ltd, a player in the healthcare services sector, has touched a new 52-week and all-time low of Rs 433.7, marking a significant decline amid a sustained downtrend. The stock has underperformed both its sector and broader market indices, reflecting ongoing pressures on its price performance.

Indegene Ltd, a healthcare services company, has reached a new all-time low price of ₹438.45 on 13 Mar 2026, marking a significant milestone in its recent market performance. The stock has been on a consistent decline, reflecting a challenging period for the company amid broader sector movements.

Indegene Ltd, a key player in the Healthcare Services sector, has declined to a fresh 52-week low of Rs.439.9, marking a significant downturn in its stock performance amid broader market pressures and sectoral headwinds.

Indegene Ltd, a key player in the Healthcare Services sector, has reached a new 52-week low of Rs.445.5, marking a significant decline amid broader market weakness and sector underperformance. The stock’s recent trajectory reflects a combination of subdued growth metrics and persistent downward pressure over the past several trading sessions.

Indegene Ltd’s share price has fallen to a new all-time low of Rs. 449.05, marking a significant milestone in its recent market performance. The stock has been on a consistent downward trajectory, reflecting a series of challenges that have impacted its valuation and returns over multiple time frames.

Indegene Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 07 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Indegene Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a bearish trend. The company’s MarketsMOJO grade was downgraded from Hold to Sell on 23 February 2026, reflecting growing concerns over its price performance and technical outlook amid broader market pressures.

Indegene Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a 3.05% gain on 26 Feb 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, prompting a downgrade in its Mojo Grade from Hold to Sell.

Indegene Ltd, a key player in the Healthcare Services sector, has seen its investment rating downgraded from Hold to Sell as of 23 February 2026, reflecting a shift in technical indicators and concerns over its long-term growth prospects despite recent positive quarterly financial results.

Indegene Ltd, a key player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This change is underscored by a series of technical indicators signalling increased downside pressure, coinciding with the company’s underperformance relative to the broader market benchmarks.

Indegene Ltd, a key player in the Healthcare Services sector, has seen its valuation parameters shift from attractive to fair, reflecting evolving market perceptions and sector dynamics. Despite a modest day gain of 0.95%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest a more tempered price attractiveness compared to historical levels and peer benchmarks.

Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 February 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Indegene Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a series of technical indicators signalling caution for investors, despite the stock’s relatively stable price near ₹491.20 as of 10 Feb 2026.

Indegene Ltd has experienced a subtle yet notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day gain of 0.61% to close at ₹482.90, the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. Investors and analysts are closely monitoring these developments as the healthcare services company navigates a challenging market environment.

Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Indegene Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a recent uptick in price, the overall technical landscape suggests caution for investors as multiple metrics reflect weakening momentum in the healthcare services stock.